New in FY2027 GLP-1 Medication Coverage for the Treatment of Obesity Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of Fiscal Year 2026 (FY3036), June 30, 2026 for non-Medicare plan members and on December 31, 2026 for Medicare plan members
Conversely, waiting more than 30 minutes to eat may increase drug absorption
doi:10.1007/s11357-014-9742-0 Barnouin Y, Armamento-Villareal R, Celli A, et al
Subcutaneous Injection (Recommended) Subcutaneous injection delivers MT-II directly into the fat layer beneath the skin, bypassing the digestive system entirely
She said the experience has felt transformative